Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | AR | P10275 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29487551 | 1.00 | CA12 (0.47) | CA12CA1CA2CA7CA13 | |
| Hydrochloric Acid SCHEMBL11812617 | 0.98 | CA12 (0.46) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11660362 | 0.88 | MAOA (0.49) | CA12CA1CA2CA7CA13 | |
| SCHEMBL10424194 | 0.85 | THRB (0.43) | MAOAMAOBMAPTARKMT2A | |
| SCHEMBL11249663 | 0.82 | CA12 (0.47) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11835307 | 0.82 | MCL1 (0.38) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11630502 | 0.81 | MEN1 (0.39) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11752648 | 0.80 | MCL1 (0.37) | MAPTARKMT2AMCL1BCL2A1 | |
| SCHEMBL10339714 | 0.80 | AR (0.60) | CA12CA1CA2CA7CA13 | |
| SCHEMBL11272357 | 0.80 | SLC2A1 (0.49) | MAOAMAPTKMT2AMCL1BCL2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462453-A | Synthesis method and application of propylthio-o-phenylenediamine | 河北美荷药业有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-115850133-B | Synthesis method of 4-propylthio-o-phenylenediamine | 山东国邦药业有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-115850133-A | Synthesis method of 4-propylthio-o-phenylenediamine | 山东国邦药业有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-111574460-B | Preparation method of albendazole | 山东国邦药业有限公司 | 2021-11-05 | — | — | CN | claimed |
| CN-108892643-B | Novel preparation method of albendazole | 常州齐晖药业有限公司 | 2021-01-08 | — | — | CN | claimed |
| CN-112125853-A | Production process and production device of albendazole | 宁夏大漠药业有限公司 | 2020-12-25 | — | — | CN | claimed |
| CN-111574460-A | Preparation method of albendazole | 山东国邦药业有限公司 | 2020-08-25 | — | — | CN | claimed |
| US-20130303782-A1 | PROCESS FOR PREPARATION OF ALBENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2013-11-14 | — | — | US | claimed |
| EP-2643304-A2 | A PROCESS FOR PREPARATION OF ALBENDAZOLE | Sequent Scientific Ltd. (IN) | 2013-10-02 | — | — | EP | claimed |
| WO-2012070069-A2 | A PROCESS FOR PREPARATION OF ALBENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-05-31 | — | — | WO | claimed |
| CN-119462453-A | Synthesis method and application of propylthio-o-phenylenediamine | 河北美荷药业有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462453-A | Synthesis method and application of propylthio-o-phenylenediamine | 河北美荷药业有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119462453-A | Synthesis method and application of propylthio-o-phenylenediamine | 河北美荷药业有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-117624055-A | Preparation method of albendazole for livestock | 河北美荷药业有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-219922937-U | Albendazole production is with alkylation reaction system | 河北美荷药业有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-0034421-A2 | N-phenyl-N'-cyano-0-phenylisoureas and process for their preparation | SMITHKLINE BECKMAN CORPORATION (US) | 1981-08-26 | — | — | EP | disclosed |
| US-4285878-A | N-Phenyl-N'-cyano-O-phenylisoureas | SMITHKLINE CORPORATION (US) | 1981-08-25 | — | — | US | disclosed |
| EP-0003951-A1 | Process for the preparation of 2-benzimidazolecarbamic acid esters | ETHYL CORPORATION (US) | 1979-09-19 | — | — | EP | disclosed |
| US-4152522-A | FROM ORTHO-NITROANILINE | ETHYL CORPORATION (US) | 1979-05-01 | — | — | US | disclosed |
| US-3956499-A | ANTHELMINTICS | SMITHKLINE CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303782-A1 | PROCESS FOR PREPARATION OF ALBENDAZOLE | CPS1, PNPO, NAT1 | CA12 989/4885CA1 1023/4885CA2 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.